Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 12, Pages 3440-3443Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm0602357
Keywords
-
Categories
Ask authors/readers for more resources
A series of isatin derivatives were synthesized and tested against SARS CoV 3C-like protease. Substitutions at the N-1 and C-5 positions were examined to elucidate the differences in substrate binding sites of the rhinovirus 3C protease and SARS CoV 3C-like protease. Compound 5f shows significant inhibition with an IC50 of 0.37 mu M. Further study showed that, unlike the irreversible covalent binding of isatin derivatives to human rhinovirus 3C protease, the compounds tested in this study are all noncovalent reversible inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available